120 related articles for article (PubMed ID: 772186)
1. An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion.
Feinstein MG; Fiekers J; Fraser C
J Pharmacol Exp Ther; 1976 Apr; 197(1):215-28. PubMed ID: 772186
[TBL] [Abstract][Full Text] [Related]
2. [Effect of tetracaine on thrombocyte aggregation and mobilization of the intracellular calcium].
Borin ML; Azizova OA; Khodorov BI
Ukr Biokhim Zh (1978); 1988; 60(3):56-60. PubMed ID: 3137702
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human platelet functions by verapamil.
Ikeda Y; Kikuchi M; Toyama K; Watanabe K; Ando Y
Thromb Haemost; 1981 Apr; 45(2):158-61. PubMed ID: 6789494
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
Fenn CG; Littleton JM
Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
[TBL] [Abstract][Full Text] [Related]
5. Ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) and the tyrphostin ST271 inhibit phospholipase C in human platelets by preventing Ca2+ entry.
Watson SP; Poole A; Asselin J
Mol Pharmacol; 1995 Apr; 47(4):823-30. PubMed ID: 7723744
[TBL] [Abstract][Full Text] [Related]
6. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
Joseph S; Krishnamurthi S; Kakkar VV
Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
[TBL] [Abstract][Full Text] [Related]
7. Unexpected effects of aurin tricarboxylic acid on human platelets.
Kinlough-Rathbone RL; Packham MA
Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo functions of thrombin-treated platelets.
Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
[TBL] [Abstract][Full Text] [Related]
9. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
10. Interrelations of platelet aggregation and secretion.
Charo IF; Feinman RD; Detwiler TC
J Clin Invest; 1977 Oct; 60(4):866-73. PubMed ID: 330568
[TBL] [Abstract][Full Text] [Related]
11. Effects of tris on responses of human and rabbit platelets to aggregating agents.
Packham MA; Guccione MA; Nina M; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1984 Apr; 51(2):140-4. PubMed ID: 6429880
[TBL] [Abstract][Full Text] [Related]
12. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets.
Okuma M; Kanaji K; Sensaki S; Uchino H
Arzneimittelforschung; 1989 Mar; 39(3):372-5. PubMed ID: 2502990
[TBL] [Abstract][Full Text] [Related]
13. Verapamil and collagen-induced platelet reactions--evidence for a role for intracellular calcium in platelet activation.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):537-40. PubMed ID: 6415847
[TBL] [Abstract][Full Text] [Related]
14. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
Rendu F; Bachelot C; Molle D; Caen J; Guez D
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
[TBL] [Abstract][Full Text] [Related]
15. Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure.
Gerrard JM; White JG; Rao GH
Am J Pathol; 1974 Nov; 77(2):151-66. PubMed ID: 4447125
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant-free prepared blood platelets and the effect of calcium on their aggregation behaviour.
Hofmann B; Lösche W; Hofmann J; Till U; Thielmann K
Artery; 1980; 8(5):437-41. PubMed ID: 6783014
[TBL] [Abstract][Full Text] [Related]
17. Clq inhibition of the interaction of collagen with human platelets.
Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
[TBL] [Abstract][Full Text] [Related]
18. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
19. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
Peerschke EI
J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
